2015

2015.04.20 Final Closing of the Investment Fund for iPS Cell and Regenerative Medicine Venture Businesses

Final Closing of the Investment Fund for iPS Cell and Regenerative Medicine Venture Businesses

2015.04.17 Alvetex® 3D cell culture platform reaches new heights with project aboard the international space station (ISS)

Alvetex® 3D cell culture platform reaches new heights with project aboard the international space station (ISS)

2015.03.20 ReproCELL will be exhibiting at AACR Annual Meeting 2015, at the booth #950.

ReproCELL will be exhibiting at AACR Annual Meeting 2015, at the booth #950. Scientific poster will also be presented (​Abstract Number/Poster Board number: ​870​/12, 860/2, 2765/27)​ on April 19th and 20th. Please stop by at our booth and poster if you attend the meeting. American Association for Cancer Research’s 106th Annual Meeting April 18-22, 2015, at the Pennsylvania Convention Center in Philadelphia, Pennsylvania Section 36 – Booth #950 Poster presentations April 19, 2015, 13:00-17:00 Poster Board 12, View Abstract 870 “PHYSICAL ACTIVITY, DIET AND OVARIAN CANCER RISK” Dr. Teresa Lehman (Chief Scientific Officer, BioServe, A ReproCELL Group Company) Poster Board 2, View Abstract 860 “EFFECTS OF BREASTFEEDING AND ORAL CONTRACEPTION […]

2015.03.20 ReproCELL will be exhibiting at SOT 2015, at the booth #1143.

ReproCELL will be exhibiting at SOT 2015, at the booth #1143. On March 26, scientific poster will also be presented about hepatotoxicity and cardiac toxicity using human iPS cell derived hepatocyte and cardiomyocyte​ ​(Abstract Number/Poster Board number: 2838 Poster Board -657 )​ Please stop by at our booth and poster if you attend the meeting. Society of Toxicology’s 54th Annual Meeting March 22–26, 2015, at the San Diego Convention Center in San Diego, California CC Sails Pavilion – Booth #1143 Poster presentation: March 26, 2015, 8:30 – 12:00 Poster Board 657, View Abstract 2838 “HUMAN iPSC-DERIVED HEPATOCYTES AND CARDIOMYOCYTES FOR DRUG TOXICITY TESTING” Dr. Mitsuru Inamura, ReproCELL

2015.03.09 Notice of the collaborative research with Japanese National Cancer Center on human epithelial cell and cancer cell culture reagents

Notice of the collaborative research with Japanese National Cancer Center on human epithelial cell and cancer cell culture reagents –

2015.03.02 Notice of introduction of next-generation sequencer – high-throughput genetic information sequencer –

Notice of introduction of next-generation sequencer – high-throughput genetic information sequencer –

2015.02.23 ReproCELL Launches Sales Collaboration with SeouLin Bioscience Co., Ltd. in Republic of Korea

ReproCELL Launches Sales Collaboration with SeouLin Bioscience Co., Ltd. in Republic of Korea

2015.02.17 Stemgent, a ReproCELL Group Company and Transposagen Biopharmaceuticals enter into a service partnership agreement providing genetically engineered stem cells

Stemgent, a ReproCELL Group Company and Transposagen Biopharmaceuticals enter into a service partnership agreement providing genetically engineered stem cells

2015.02.16 Additional Explanation regarding 3Q FY March 2015 Consolidated Financial Results

Additional Explanation regarding 3Q FY March 2015 Consolidated Financial Results

2015.02.09 ReproCELL Launches Global Sales Collaboration with Revive Organtech, INC.

ReproCELL Launches Global Sales Collaboration with Revive Organtech, INC.